140 related articles for article (PubMed ID: 8628368)
1. Intensity of hemodialysis and response to erythropoietin.
Uréna P; Pétrover M
N Engl J Med; 1996 Jun; 334(25):1669; author reply 1670-1. PubMed ID: 8628368
[No Abstract] [Full Text] [Related]
2. Intensity of hemodialysis and response to erythropoietin.
Kotanko P
N Engl J Med; 1996 Jun; 334(25):1670; author reply 1670-1. PubMed ID: 8628371
[No Abstract] [Full Text] [Related]
3. Intensity of hemodialysis and response to erythropoietin.
Malhotra D; Tzamaloukas AH
N Engl J Med; 1996 Jun; 334(25):1669-70; author reply 1670-1. PubMed ID: 8628369
[No Abstract] [Full Text] [Related]
4. [Beneficial effect of AN69 membranes on anemia in hemodialyzed patients].
García Cortés MJ; Sánchez Perales MC; Liébana A; Gil JM; Borrego FJ; Borrego J; Pérez del Barrio P; Serrano P; Pérez Bañasco V
Nefrologia; 2001; 21(4):370-5. PubMed ID: 11816513
[TBL] [Abstract][Full Text] [Related]
5. [Use of erythropoietin in patients with chronic renal insufficiency and in hemodialysis].
Cuero CJ; Pérez Guardia E; de Rivera C
Rev Med Panama; 1996; 21(1-2):55-9. PubMed ID: 8966240
[TBL] [Abstract][Full Text] [Related]
6. Effects of erythropoietin in predialysis patients.
Anderson S
Am J Kidney Dis; 1991 May; 17(5 Suppl 1):103-6. PubMed ID: 2024665
[No Abstract] [Full Text] [Related]
7. [A hematocrit greater than 36 lessens mortality and hospitalization in hemodialysis].
Fernández-Gallego J; Gutiérrez C
Nefrologia; 2003; 23(2):177-8. PubMed ID: 12778885
[No Abstract] [Full Text] [Related]
8. [Low doses of recombinant erythropoietin in the treatment of renal anemia in patients on chronic hemodialysis and ambulatory peritoneal dialysis].
Lashutin SV; Nikolaev AIu; Ermolenko VM; Shutov EV; Bezruk VG; Ivashchenko MA
Ter Arkh; 1999; 71(6):61-3. PubMed ID: 10420460
[TBL] [Abstract][Full Text] [Related]
9. Intensity of hemodialysis and response to erythropoietin.
Ballinger AB; Fairclough PD; Clark ML; Farthing MJ
N Engl J Med; 1996 Jun; 334(25):1670; author reply 1670-1. PubMed ID: 8628370
[No Abstract] [Full Text] [Related]
10. [Etiopathogenic mechanisms of anemia in hemodialysis patients].
Marco Franco JE; Alarcón Zurita A; Dalmau Diana M; Pizá Buñola C; Morey Molina A; Bestard Palmer J; Mairata Bosch S; Ribas Mundó M
Rev Clin Esp; 1983 Jan; 168(2):83-5. PubMed ID: 6344155
[No Abstract] [Full Text] [Related]
11. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
Korbet SM
Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
[No Abstract] [Full Text] [Related]
12. Dialysis dose, membrane type, and anemia control.
Young EW
Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S157-60. PubMed ID: 9892384
[TBL] [Abstract][Full Text] [Related]
13. Normalization of hematocrit in regular hemodialysis patients: the role of renal cyst formation.
Ono K; Kikawa K; Okamoto T; Matsuo H
Trans Am Soc Artif Intern Organs; 1985; 31():639-43. PubMed ID: 3837523
[No Abstract] [Full Text] [Related]
14. [Countermeasure for patients with anemia due to hemodialysis].
Suzuki M
Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1663-7. PubMed ID: 8537721
[No Abstract] [Full Text] [Related]
15. [Evolution of medical practice in the care of anemia amd the use of erythropoietin in chronic renal insufficiency hemodialysis in the past six years].
Canaud B; Richard A; Fagnani F; Moreau-Defarges T; Guillon P
Nephrologie; 2002; 23(3):123-30. PubMed ID: 12087809
[TBL] [Abstract][Full Text] [Related]
16. [The effect of calcitriol on renal anemia in patients under chronic hemodialysis].
Abou-Khalil N; Makó J
Orv Hetil; 1996 Jul; 137(27):1469-72. PubMed ID: 9173368
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin treatment for anemia in end-stage renal disease with diabetes mellitus.
Nakatsuka K; Hino M; Miki T; Nishizawa Y; Tabata T; Inoue T; Morii H
Diabetes Care; 1990 Nov; 13(11):1130-1. PubMed ID: 2261828
[No Abstract] [Full Text] [Related]
18. Anemia in patients on maintenance hemodialysis: the effect of parathyroid hormone.
Kostić S; Strahinjić S; Dordević V; Stefanović V
Acta Med Iugosl; 1986; 40(2):133-7. PubMed ID: 3728075
[No Abstract] [Full Text] [Related]
19. The use of IV iron in the treatment of anaemia of ESRD patients on maintenance haemodialysis: an historical and personal view.
Shaldon S
Nephrol Dial Transplant; 2007 Jan; 22(1):23-5. PubMed ID: 17088269
[No Abstract] [Full Text] [Related]
20. Reticulocyte count used to assess recombinant human erythropoietin sensitivity in hemodialysis patients.
Tatsumi N; Kojima K; Tsuda I; Yamagami S; Itoh Y; Tanaka H
Contrib Nephrol; 1990; 82():41-8. PubMed ID: 2093525
[No Abstract] [Full Text] [Related]
[Next] [New Search]
